Search Results
Aug 05, 2026, 08:00 ET Neurvati Neurosciences Strengthens Executive Leadership Team to Advance Next Phase of Growth at GRIN Therapeutics
every part of our organization. This promotion recognizes the tremendous impact he has had across both Neurvati and GRIN Therapeutics."About GRIN Therapeutics GRIN Therapeutics, Inc. is dedicated to the research and development of precision therapeutics for neurodevelopmental disorders
More news about: Neurvati Neurosciences
Jul 15, 2026, 12:35 ET Track-Ready 2026 Hyundai IONIQ 5 N Priced at $59,900, Now More Attainable Than Ever
price drop makes this thrilling all-electric N experience accessible to more enthusiastsIONIQ 5 N delivers up to 641 horsepower with N Grin Boost engagedFOUNTAIN VALLEY, Calif., July
More news about: Hyundai Motor America
Jun 24, 2026, 12:33 ET Start Genetic Announces Second Annual Genetic Testing Action Day on July 25, 2026
industry partners.This year's campaign is supported by our lead sponsor Illumina, and supporting sponsors PYC Therapeutics, Neuren Pharmaceuticals, GRIN Therapeutics, Jaguar Gene Therapy, MyOme, anonymous donors, and a growing coalition of organizations committed to improving awareness and access to
More news about: Start Genetic
Jun 04, 2026, 13:00 ET SPIRIT HACKS INTO SUMMERWEEN WITH LIMITED EDITION TERRIFIER COLLECTION
Clown Ice Cream Inflatable Pool Float: a nearly six-foot Art-inspired ice cream cone topped with his iconic sunflower shades and devious grin.
More news about: Spencer Gifts LLC and Spirit Halloween Superstores LLC
Jun 04, 2026, 10:00 ET Devil's Grin Texas Gin Launches "America's Craft Gin" for a New Generation of Gin Drinkers
drinkers," says Brett Luchesi, Master Distiller of Devil's Grin Texas Gin. "I created Devil's Grin Gin with a delicate complexity that showcases every botanical, while still feeling approachable and easy to enjoy. We want Devil's Grin to feel connected to how people socialize, bringing people together
More news about: Devil's Grin Texas Gin
May 04, 2026, 07:00 ET GRIN Therapeutics' Pivotal Phase 3 Beeline Study Initiated in Europe
and functional outcomes."This is an exciting and meaningful milestone for GRIN Therapeutics and, more importantly, for the GRIN-NDD community," said Bruce Leuchter, MD, President and Chief Executive Officer of GRIN Therapeutics. "Expanding the Beeline study into Europe brings us closer to delivering
More news about: GRIN Therapeutics Inc.
Apr 28, 2026, 06:30 ET Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
advancing therapeutic candidates in neurological and psychiatric disorders. This included serving as Chief Medical Officer of Neurvati's first sub-company, GRIN Therapeutics, overseeing development of radiprodil, a negative allosteric modulator targeting the NMDA receptor as a potential treatment for rare genetically
More news about: Immunic, Inc.
Apr 02, 2026, 03:00 ET Hyundai IONIQ 6 N Crowned 2026 World Performance Car
sophisticated, driver-focused technology for both track and road.Exceptional Performance: IONIQ 6 N delivers up to 641 hp with N Grin Boost, accelerating from 0 to 62 mph in just 3.2 seconds.Driver-Focused Features: N e-Shift provides the feel of a real gearshift, while
More news about: Hyundai Motor Company
Feb 16, 2026, 11:05 ET Hyundai IONIQ 5 N Named Best Performance EV by Car Talk
pillars of performance: Corner Rascal' Racetrack Capability, and Everyday Sportscar. Its electric motors provide up to 641 horsepower (478 kW) with N Grin Boost[i] engaged. Far beyond rapid all-electric performance, IONIQ 5 N offers novel driver-focused technologies like N e-Shift and N Active Sound+ to
More news about: Hyundai Motor America
Feb 14, 2026, 06:00 ET Battat Joins the World of Collectibles
there's a Pa for everyone. Collecting begins this April at Target, with prices ranging from $12 to $16.A new mischief is in town. With a subtle grin, Monboo introduces himself as a dream-chaser with a deep love for nature. His distinctive personality makes him undeniably lovable and collectible.
More news about: Battat
Feb 10, 2026, 12:03 ET Cultural wave of 'becoming Chinese' gains momentum
"ugly-cute" doll, created by Hong Kong-born illustrator Kasing Lung and propelled by the Chinese brand Pop Mart, became a global phenomenon. Its whimsical grin, brandished by celebrities from Blackpink star Lisa to David Beckham, proved that Chinese creativity could define cool. The frenzy was undeniable — a
More news about: China Daily
Feb 03, 2026, 08:54 ET HUNTER×HUNTER Immersive Experience "The Hunter Exam: Battle of Wits 2026" Arrives in Los Angeles
of fierce contenders amidst a deadly mind game. A supernatural incident brought about by a mysterious ability.And with a sly grin on his face appears Hisoka the magician!This grueling exam will push your abilities to the limits. Do you have what it takes to pass?About
More news about: SCRAP Co., Ltd.
Jan 14, 2026, 09:57 ET 113 Epilepsy Organizations Unite to Express Concerns about Leadership Change at the National Institute of Neurological Disorders and Stroke
AmericaFamilieSCN2A Foundation Families of SCAMP5GABA-A AllianceGlobal GenesGNB1 Advocacy GroupGRIN2B FoundationHidden Truths ProjectHope for HIEHope for ULDInternational Foundation for CDKL5 ResearchInternational
More news about: Epilepsy Foundation
Jan 13, 2026, 09:15 ET Creative Planning Acquires First International RIA, Baseline Wealth Management
Planning's comprehensive suite of services while also allowing Creative Planning to offer a Swiss wealth management solution," said Baseline CEO Thierry Grin. "Peter's vision, sustained success and visionary leadership, along with his extraordinary team, including David Kuenzi and talented M&A advisors,
More news about: Creative Planning, LLC
Jan 13, 2026, 03:15 ET Creative Planning erwirbt mit Baseline Wealth Management den ersten internationalen RIA
Dienstleistungsangebot von Creative Planning und gleichzeitig kann Creative Planning eine Schweizer Vermögensverwaltungslösung anbieten", so Thierry Grin, CEO von Baseline. "Peters Vision, sein nachhaltiger Erfolg und seine visionäre Führung, zusammen mit seinem außergewöhnlichen Team, einschließlich David
More news about: Creative Planning, LLC
Jan 13, 2026, 03:15 ET Creative Planning Acquires First International RIA, Baseline Wealth Management
Planning's comprehensive suite of services while also allowing Creative Planning to offer a Swiss wealth management solution," said Baseline CEO Thierry Grin. "Peter's vision, sustained success and visionary leadership, along with his extraordinary team, including David Kuenzi and talented M&A advisors,
More news about: Creative Planning, LLC
Jan 13, 2026, 03:15 ET Creative Planning acquiert la première RIA internationale, Baseline Wealth Management
de services de Creative Planning, tout en permettant à Creative Planning d'offrir une solution suisse de gestion de patrimoine", a déclaré Thierry Grin, directeur général de Baseline. "La vision de Peter, son succès durable et son leadership visionnaire, ainsi que son équipe extraordinaire, dont David
More news about: Creative Planning, LLC
Jan 09, 2026, 07:30 ET GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder
the efficacy and safety of investigational radiprodil in patients with GRIN-NDD who have confirmed gain-of-function variants. The trial incorporates a disease-specific endpoint, the GRIN-specific Clinical Global Impression (GRIN-CGI) scale developed in collaboration with caregivers, as well as traditional
More news about: GRIN Therapeutics Inc.
Jan 06, 2026, 07:00 ET Industry Veteran Jonathan Freeman, Ph.D. Joins ARTBIO As Chief Business Officer
group of Merck KGaA. His prior experience includes leadership roles at Baxter International and Serono. Jonathan co-founded Neurvati Neurosciences and GRIN Therapeutics and has been involved with several drug approvals and new product launches. He received his Ph.D. from Cancer Research UK and an M.A. (Cantab)
More news about: ARTBIO
Dec 03, 2025, 07:00 ET GRIN Therapeutics to Present on Global Phase 3 Beeline Clinical Trial of Radiprodil at American Epilepsy Society Annual Meeting
behavioral changes, in currently recruiting Phase 3 study in GRIN-related neurodevelopmental disorder (GRIN-NDD)NEW YORK, Dec. 3, 2025 /PRNewswire/ -- GRIN Therapeutics, Inc., a leader in the development of targeted disease-specific
More news about: GRIN Therapeutics Inc.
Nov 20, 2025, 12:50 ET Hyundai IONIQ 6 N High-Performance EV Supercharges AutoMobility LA with North American Premiere
3 Only use the N Race, N Drift Optimizer, N Launch Control, N Grin Boost, and Track SOC features on a closed racetrack and with extreme caution. Never use N Race, N Drift Optimizer, N Launch Control, N Grin Boost, or Track SOC on public roads. Frequent use of these features can weaken
More news about: Hyundai Motor America
Nov 13, 2025, 07:00 ET Neurvati Neurosciences Appoints Carlos Martin as Chief Commercial Officer
GRIN Therapeutics reported promising topline data from a Phase 1b/2a clinical trial (the Honeycomb Trial, ClinicalTrials.gov identifier: NCT05818943) evaluating investigational radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD) in patients with gain-of-function
More news about: Neurvati Neurosciences
Oct 20, 2025, 11:00 ET Resistance to Epilepsy Treatments May Wane Over Time
Cowen and Co., Crossject, EcoR1 Capital, Eisai Co., Encoded Therapeutics, Engrail, EpiMinder, Epitel, Équilibre BioPharmaceuticals Corp., Genentech, GRIN Therapeutics, Harmony Biosciences/Epygenix Therapeutics, iQure Pharma, IQVIA, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Korro Bio, Leal Therapeutics,
More news about: NYU Grossman School of Medicine and NYU Langone Health
Oct 09, 2025, 11:00 ET Search Party emerges from stealth with $3.5 million to help brands track & control their AI visibility
Brandon and Ryan Brown were previously two of the co-founders of GRIN, the world's leading creator management platform and Sacramento's first tech unicorn. Under Brandon's leadership as CEO, GRIN grew from $0 to $1 billion in valuation, raised $145 million across seven
More news about: Search Party
Oct 09, 2025, 08:39 ET A Frenchman's Thanksgiving: JP Bourgeois Shares the Insider Wines He Pours at His Own Table
Bourgeois, a Frenchman who's built his life in the U.S., it's become one of his favorites. "In France, we don't have Thanksgiving," JP says with a grin. "But what could be more French than gathering with family, eating too much, and making sure there's always another bottle open?"
More news about: JP Bourgeois Wine Imports